scispace - formally typeset
G

Giuseppe Mancia

Researcher at University of Milano-Bicocca

Publications -  1465
Citations -  152794

Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.

Papers
More filters
Journal ArticleDOI

Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.

Guido Grassi, +4 more
- 22 Jul 2007 - 
TL;DR: Evidence is reviewed that drugs acting on the renin-angiotensin system may exert cerebrovascular protective effects additive to the ones associated with blood pressure reduction on this end point.
Journal ArticleDOI

Evidence-based medicine: an educational instrument or a standard for implementation?

Giuseppe Mancia, +1 more
- 01 Nov 1999 - 
Journal ArticleDOI

Multiple sampling improves norepinephrine reproducibility in essential hypertension: A comparison with the microneurographic technique

Guido Grassi, +5 more
- 01 Nov 2008 - 
TL;DR: In essential hypertension, the reproducibility of plasma norepinephrine as an adrenergic marker can be substantially improved by performing a nore Pinephrine assay on multiple blood samples.
Journal ArticleDOI

Ambulatory blood pressure monitoring and antihypertensive treatment

Giuseppe Mancia, +2 more
- 01 Dec 1992 - 
TL;DR: It will be argued that due to lack of prognostic validity and high cost, ABPM should not be employed routinely in treating hypertensives, but it should always be employed for the evaluation of the efficacy of new hypertensive drugs for which its superiority over sphygmomanometry is indisputable.
Journal ArticleDOI

Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk.

Colomba Falcone, +10 more
- 01 Jan 2013 - 
TL;DR: This study confirms the robust and widely studied role of CRP as an important marker of vascular inflammation and postulates the possible involvement of sRAGE and eotaxin, 2 novel biomarkers, in CVDs.